These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26956846)

  • 1. The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus.
    Pacilli A; Prudente S; Copetti M; Fontana A; Mercuri L; Bacci S; Marucci A; Alberico F; Viti R; Palena A; Lamacchia O; Cignarelli M; De Cosmo S; Trischitta V
    Endocrine; 2016 Oct; 54(1):38-46. PubMed ID: 26956846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
    Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
    Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies.
    De Cosmo S; Prudente S; Lamacchia O; Lapice E; Morini E; Di Paola R; Copetti M; Ruggenenti P; Remuzzi G; Vaccaro O; Cignarelli M; Trischitta V
    Nephrol Dial Transplant; 2011 Dec; 26(12):4011-6. PubMed ID: 21493814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between PPARγ2 Pro12Ala polymorphism and type 2 diabetes mellitus in Chinese Han population: a Meta-analysis].
    Tong JY; Huang N; Wang L; Yi YS; Pan XH; Lü Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Apr; 46(4):359-63. PubMed ID: 22800638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
    Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
    Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
    J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
    Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
    Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome.
    Fiorito M; Torrente I; De Cosmo S; Guida V; Colosimo A; Prudente S; Flex E; Menghini R; Miccoli R; Penno G; Pellegrini F; Tassi V; Federici M; Trischitta V; Dallapiccola B
    Obesity (Silver Spring); 2007 Dec; 15(12):2889-95. PubMed ID: 18198294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
    Lapice E; Monticelli A; Cocozza S; Pinelli M; Cocozza S; Bruzzese D; Riccardi G; Vaccaro O
    J Transl Med; 2015 Mar; 13():85. PubMed ID: 25889595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms.
    Baratta R; Di Paola R; Spampinato D; Fini G; Marucci A; Coco A; Vigneri R; Frittitta L; Trischitta V
    J Mol Med (Berl); 2003 Nov; 81(11):718-23. PubMed ID: 14574455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MTHFR and PPARγ2 gene polymorphisms in relation to type 2 diabetes mellitus cases among north Indian population.
    Raza ST; Abbas S; Ahmed F; Fatima J; Zaidi ZH; Mahdi F
    Gene; 2012 Dec; 511(2):375-9. PubMed ID: 23036708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C161-->T polymorphism in peroxisome proliferator-activated receptor gamma, but not P12A, is associated with insulin resistance in Hispanic and non-Hispanic white women: evidence for another functional variant in peroxisome proliferator-activated receptor gamma.
    Moffett SP; Feingold E; Barmada MM; Damcott CM; Marshall JA; Hamman RF; Ferrell RE
    Metabolism; 2005 Nov; 54(11):1552-6. PubMed ID: 16253648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.
    Stumvoll M; Stefan N; Fritsche A; Madaus A; Tschritter O; Koch M; Machicao F; Häring H
    J Mol Med (Berl); 2002 Jan; 80(1):33-8. PubMed ID: 11862322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
    Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
    Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and type 2 diabetes in an Arab population.
    Wakil SM; Al-Rubeaan K; Alsmadi O; Imtiaz F; Carroll P; Rajab M; Al-Katari S; Al-Katari M; Meyer BF
    Diabetes Care; 2006 Jan; 29(1):171-2. PubMed ID: 16373923
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
    Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk.
    Wang C; Li X; Huang Z; Qian J
    Mol Biol Rep; 2013 Feb; 40(2):811-7. PubMed ID: 23054024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.